A droplet digital PCR detection method for rare L1 insertions in tumors

Area of Science:

• Genomics
• Molecular Biology
• Cancer Research

Background:

• The human genome contains over 500,000 copies of the active mobile element, long interspersed element 1 (L1).
• L1 mobilization, via target primed reverse transcription (TPRT), causes human diseases and is linked to various cancers.
• High-throughput sequencing (HTS) advances understanding of L1 in cancer, but validating rare L1 insertions in tumors remains challenging due to detection limitations.

Purpose of the Study:

• To develop and validate a sensitive method for detecting rare L1 insertion events in mosaic human genomes.
• To overcome the limitations of HTS in identifying and quantifying low-frequency L1 insertions in clinical samples.

Main Methods:

• Utilized droplet digital PCR (ddPCR) to detect and quantify L1 loci.
• Developed a ddPCR assay capable of identifying L1 insertions at low allele frequencies.

Main Results:

• The ddPCR assay successfully detected L1 insertions at a frequency as low as one in 10,000 cells.
• Demonstrated the robustness of ddPCR for identifying rare L1 events in mosaic genomes.

Conclusions:

• Droplet digital PCR (ddPCR) is a powerful tool for detecting, validating, and quantifying rare L1 insertion events.
• ddPCR complements HTS methods, improving the analysis of L1 in cancer and other mosaic tissues.